These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16291423)

  • 41. [Combination chemotherapy in the treatment of inoperable non-small cell lung cancer].
    Masuda N
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():379-83. PubMed ID: 9369911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.
    Bepler G; Dilling TJ; Wagner H; Hazelton T; Williams C; Chen DT; Greenberg H; Walsh F; Simon G; Tanvetyanon T; Chiappori A; Haura E; Stevens C
    J Thorac Oncol; 2011 Mar; 6(3):553-8. PubMed ID: 21289520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer.
    Belani CP; Aisner J
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):79-90. PubMed ID: 8052878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
    Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carboplatin/gemcitabine combination in advanced NSCLC.
    Ramalingam S; Belani CP
    Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):21-6. PubMed ID: 15339055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.
    Gagel B; Piroth M; Pinkawa M; Reinartz P; Krohn T; Kaiser HJ; Stanzel S; Breuer C; Asadpour B; Schmachtenberg A; Eble MJ
    BMC Cancer; 2007 Jun; 7():112. PubMed ID: 17598906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.
    Cappuzzo F; Selvaggi G; Gregorc V; Mazzoni F; Betti M; Rita Migliorino M; Novello S; Maestri A; De Marinis F; Darwish S; De Angelis V; Nelli F; Bartolini S; Scagliotti GV; Tonato M; Crinò L
    Cancer; 2003 Jul; 98(1):128-34. PubMed ID: 12833465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.
    Casal J; Amenedo M; Mel JR; Antón LM; Rodríguez-López R; López-López R; González-Ageitos A; Castellanos J; Constenla M; Tisaire JL
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):725-32. PubMed ID: 17273825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?
    Gridelli C
    Lung Cancer; 2002 Nov; 38 Suppl 2():S45-50. PubMed ID: 12431829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Open-Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non-Small Cell Lung Cancer.
    Patil PD; Shapiro M; Hashemi Sadraei N; Pennell NA
    Oncologist; 2019 Apr; 24(4):457-e126. PubMed ID: 30602615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.
    Kosmas C; Tsavaris N; Mylonakis N; Kalofonos HP
    Crit Rev Oncol Hematol; 2003 Mar; 45(3):265-75. PubMed ID: 12633839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
    Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
    J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.
    Harper P
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):2-12. PubMed ID: 12917815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer.
    Ke QH; Zhou SQ; Yang JY; Du W; Liang G; Lei Y; Luo F
    World J Gastroenterol; 2014 Oct; 20(38):13987-92. PubMed ID: 25320537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiosensitization with chemotherapeutic agents.
    Caffo O
    Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.
    Le Chevalier T; Scagliotti G; Natale R; Danson S; Rosell R; Stahel R; Thomas P; Rudd RM; Vansteenkiste J; Thatcher N; Manegold C; Pujol JL; van Zandwijk N; Gridelli C; van Meerbeeck JP; Crino L; Brown A; Fitzgerald P; Aristides M; Schiller JH
    Lung Cancer; 2005 Jan; 47(1):69-80. PubMed ID: 15603856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer.
    ten Bokkel Huinink WW; Bergman B; Chemaissani A; Dornoff W; Drings P; Kellokumpu-Lehtinen PL; Liippo K; Mattson K; von Pawel J; Ricci S; Sederholm C; Stahel RA; Wagenius G; Walree NV; Manegold C
    Lung Cancer; 1999 Nov; 26(2):85-94. PubMed ID: 10568679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer.
    Abacioglu U; Yumuk PF; Caglar H; Sengoz M; Turhal NS
    BMC Cancer; 2005 Jul; 5():71. PubMed ID: 16000167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease.
    Choi MK; Hong JY; Chang W; Kim M; Kim S; Jung HA; Lee SJ; Park S; Chung MP; Sun JM; Park K; Ahn MJ; Ahn JS
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1217-25. PubMed ID: 24696125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].
    Zhang L; Zhang Y; Li N; Xu F; Pan ZK; Guan ZZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1455-8. PubMed ID: 15566656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.